Global Chicken Newcastle Disease Vaccine Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application
Published on: 2024-01-04 | No of Pages : 400 | Industry : Medical
Publisher : MRA | Format : PDF
Global Chicken Newcastle Disease Vaccine Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application
Chicken Newcastle Disease Vaccine is a monovalent live virus vaccine for the immunization of chickens against Newcastle disease.
Chicken Newcastle Disease Vaccine report published by MRAResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Chicken Newcastle Disease Vaccine market is projected to reach US$ million in 2033, increasing from US$ million in 2022, with the CAGR of % during the period of 2023 to 2033. Demand from Chicken and Adult Chicken are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Chicken Newcastle Disease Vaccine industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2023 to 2033.
Globally, Chicken Newcastle Disease Vaccine key manufacturers include Boehringer-Ingelheim, Merial, CEVA, MRAH Biotech, Merck Animal Health, Zoetis, Elanco (Lohmann), FATRO and Vaksindo, etc. Boehringer-Ingelheim, Merial, CEVA are top 3 players and held % sales share in total in 2022.
Chicken Newcastle Disease Vaccine can be divided into Live Vaccine and Inactivated Vaccine, etc. Live Vaccine is the mainstream product in the market, accounting for % sales share globally in 2022.
Chicken Newcastle Disease Vaccine is widely used in various fields, such as Chicken and Adult Chicken, etc. Chicken provides greatest supports to the Chicken Newcastle Disease Vaccine industry development. In 2022, global % sales of Chicken Newcastle Disease Vaccine went into Chicken filed.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2033), aims to help readers to get a comprehensive understanding of global Chicken Newcastle Disease Vaccine market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report
Boehringer-Ingelheim
Merial
CEVA
MRAH Biotech
Merck Animal Health
Zoetis
Elanco (Lohmann)
FATRO
Vaksindo
Ringpu
Yebio
Harvac
Chengdu SG-Biotech
Harbin Pharmaceutical Group
Segment by Type
Live Vaccine
Inactivated Vaccine
Chicken
Adult Chicken
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Chicken Newcastle Disease Vaccine market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2023.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Chicken Newcastle Disease Vaccine, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Chicken Newcastle Disease Vaccine industry.
Chapter 3Historical (2018-2022) and forecast (2023-2033) volume and revenue analysis of Chicken Newcastle Disease Vaccine in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2023.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Chicken Newcastle Disease Vaccine introduction, etc. Chicken Newcastle Disease Vaccine Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13MRAResearch’s Conclusions of Chicken Newcastle Disease Vaccine market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by MRAResearch.
Chicken Newcastle Disease Vaccine report published by MRAResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Chicken Newcastle Disease Vaccine market is projected to reach US$ million in 2033, increasing from US$ million in 2022, with the CAGR of % during the period of 2023 to 2033. Demand from Chicken and Adult Chicken are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Chicken Newcastle Disease Vaccine industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2023 to 2033.
Globally, Chicken Newcastle Disease Vaccine key manufacturers include Boehringer-Ingelheim, Merial, CEVA, MRAH Biotech, Merck Animal Health, Zoetis, Elanco (Lohmann), FATRO and Vaksindo, etc. Boehringer-Ingelheim, Merial, CEVA are top 3 players and held % sales share in total in 2022.
Chicken Newcastle Disease Vaccine can be divided into Live Vaccine and Inactivated Vaccine, etc. Live Vaccine is the mainstream product in the market, accounting for % sales share globally in 2022.
Chicken Newcastle Disease Vaccine is widely used in various fields, such as Chicken and Adult Chicken, etc. Chicken provides greatest supports to the Chicken Newcastle Disease Vaccine industry development. In 2022, global % sales of Chicken Newcastle Disease Vaccine went into Chicken filed.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2033), aims to help readers to get a comprehensive understanding of global Chicken Newcastle Disease Vaccine market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report
By Company
Boehringer-Ingelheim
Merial
CEVA
MRAH Biotech
Merck Animal Health
Zoetis
Elanco (Lohmann)
FATRO
Vaksindo
Ringpu
Yebio
Harvac
Chengdu SG-Biotech
Harbin Pharmaceutical Group
Segment by Type
Live Vaccine
Inactivated Vaccine
Segment by Application
Chicken
Adult Chicken
Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Chicken Newcastle Disease Vaccine market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2023.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Chicken Newcastle Disease Vaccine, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Chicken Newcastle Disease Vaccine industry.
Chapter 3Historical (2018-2022) and forecast (2023-2033) volume and revenue analysis of Chicken Newcastle Disease Vaccine in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2023.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Chicken Newcastle Disease Vaccine introduction, etc. Chicken Newcastle Disease Vaccine Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13MRAResearch’s Conclusions of Chicken Newcastle Disease Vaccine market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by MRAResearch.